Polysaccharide Hydrogels for Tissue Bonding and Hemostasis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current hydrogel formulations in biomedical applications face limitations due to poor mechanical performance, inadequate binding to tissue surfaces, and inconsistent hemostatic control, lacking a material that consistently provides multiple desirable qualities such as hemostasis, adhesion, infection control, and minimal tissue response.

Innovation Solution

Polysaccharide-based hydrogel compositions are developed by combining a polysaccharide component with a hydrophilic polymer and a cross-linking agent, which form a cohesive hydrogel capable of bonding to tissue in both wet and dry environments, offering improved mechanical properties and multi-functional benefits like hemostasis, adhesion, and biocompatibility.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If hydrogels are used to improve biocompatibility in medical devices, then biocompatibility and reduced thrombosis tendency are improved, but mechanical performance deteriorates with low modulus, low yield stress, and low strength

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidmechanical strength
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent uses composite materials by combining hydrogel networks with reinforcing fillers (such as nanocellulose, nanofibers, or particles) to create a hybrid structure that maintains the biocompatibility of hydrogels while gaining the mechanical strength of the filler materials. This composite approach allows the material to exhibit both liquid-like properties from water and solid-like mechanical properties from the cross-linked network and filler reinforcement.

Inventive Principle:
Principle #40Composite materials

2Reliability

If hydrogels are formulated with swelling agents to achieve hydrophilic properties, then biocompatibility is improved, but mechanical performance deteriorates due to non-stress bearing nature of the swelling agent

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidstress bearing capacity
Core Design Contradiction:
ReliabilityVSStress or pressure

Solution Approach 1:

The patent changes the physical and chemical parameters of the hydrogel system by controlling cross-linking density, polymer concentration, and filler content to optimize the balance between hydrophilicity (for biocompatibility) and stress-bearing capacity. By adjusting these parameters, the hydrogel can maintain adequate water content for biocompatibility while developing sufficient mechanical strength through enhanced network structure.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If existing hydrogel materials are used to provide hemostatic control, then hemostasis is addressed, but consistency and reliability deteriorate

Engineering Contradiction:
Improvehemostatic controlVSAvoidconsistency
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent incorporates feedback mechanisms through controlled cross-linking reactions and standardized formulation protocols that ensure consistent hemostatic performance. The cross-linking process creates a predictable network structure that reliably controls blood clotting, while quality control measures maintain batch-to-batch consistency in hemostatic activity.

Inventive Principle:
Principle #23Feedback

4Reliability

If hydrogels are used as coatings due to insufficient mechanical performance, then biocompatibility is improved, but device functionality deteriorates when used as bulk polymer

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidapplication versatility
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent creates dynamic hydrogel systems that can transition between different mechanical states or adapt their properties based on environmental conditions. This dynamic behavior allows the material to function as a coating when applied in thin layers while maintaining sufficient mechanical integrity for bulk applications, expanding the versatility of hydrogel-based medical devices.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The polysaccharide-based hydrogels provide enhanced mechanical performance, consistent hemostatic control, and biocompatibility, allowing for effective tissue bonding and regeneration while minimizing inflammatory responses, thus addressing the limitations of existing hydrogel materials.

Implementation Method 1

the most common synthetic route is the free radical polymerization of vinyl monomers in the presence of a difunctional cross-linking agent and a swelling agent

Methodology Applied
Scientific EffectCross-linking: Chemical Bonding

Implementation Method 2

Hydrogels are water-swollen networks of hydrophilic homopolymers or copolymers

Methodology Applied
Scientific EffectHydrophilic interaction: Solvation

Data Source

PatentUS9700650B2Polysaccharide based hydrogels
Publication Date: 2017.07.11 STRYKER CORP
  • US9700650B2 patent drawing
  • US9700650B2 patent drawing
  • US9700650B2 patent drawing

AI summary

Polysaccharide based hydrogel compositions and methods of making and using the same are provided. The subject polysaccharide based hydrogel compositions are prepared by combining a polysaccharide component with a hydrophilic polymer and a cross-linking agent. Also provided are kits and systems for use in preparing the subject compositions.